LivingGLP1
Study S001141

How GLP-1 Analogues Prevent Steroid-Induced Diabetes

ClinicalTrials.gov record

Registration

Registration
NCT06318442
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Status
RECRUITING
Enrollment
60
Start
2024-05-15
Primary completion
2027-06-01
Lead sponsor
Imperial College London
Conditions
Steroid-Induced Diabetes; Steroid Induced Hyperglycemia
Interventions
DRUG:Semaglutide Oral Product; DRUG:Metformin Oral Tablet; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • Difference in Glucose tolerance [Through study completion, on day 7 dexamethasone and study medication]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.